India, Sept. 15 -- Something meaningful is shifting in where healthcare research in India begins. Not dramatically, but steadily, and in a direction the pharmaceutical and healthtech industry would do well to notice.

Across undergraduate and postgraduate programmes in medicine, life sciences, and biomedical engineering, a growing number of students are attempting to tackle problems with immediate diagnostic, therapeutic, and public-health relevance.

What distinguishes their work is a quality that corporate R&D pipelines- optimised, rightly, for regulatory timelines and commercial return are rarely structured to produce: it is grounded in the day-to-day constraints of community health, and approached without the assumptions that settle i...